Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2008 | 06-2008 | 12-2007 | 06-2007 | 12-2006 | |
| Sales | 0 | 450 | 6 | 300 | 180 |
| Gross Profit | 0 | 450 | 6 | 300 | 180 |
| Operating Expenses | 570 | 4,710 | 1,250 | 3,610 | 1,330 |
| Operating Income | -570 | -4,260 | -1,244 | -3,310 | -1,150 |
| Interest Expense | 0 | 430 | 60 | 0 | 0 |
| Other Income | 0 | 90 | 14 | 60 | 20 |
| Pre-tax Income | -570 | -4,600 | -1,290 | -3,250 | -1,130 |
| Net Income Continuous | -4,601 | -4,601 | -3,315 | -3,315 | -3,315 |
| Net Income | $-4,601 | $-4,600 | $-1,290 | $-3,250 | $-1,130 |
| EPS Basic Total Ops | -20,800.00 | -520.00 | -16,800.00 | -420.00 | -16,800.00 |
| EPS Basic Continuous Ops | -23,005.00 | -522.84 | -16,575.00 | -430.52 | -16,575.00 |
| EPS Diluted Total Ops | -20,800.00 | -520.00 | -16,800.00 | -420.00 | -16,800.00 |
| EPS Diluted Continuous Ops | -23,005.00 | -522.84 | -16,575.00 | -430.52 | -16,575.00 |
| EBITDA(a) | $-310 | $-3,500 | $-904 | $-3,150 | $-1,140 |